Suppr超能文献

急性及具有临床相关性的药物性肝损伤:一项基于人群的病例对照研究。

Acute and clinically relevant drug-induced liver injury: a population based case-control study.

作者信息

de Abajo Francisco J, Montero Dolores, Madurga Mariano, García Rodríguez Luis A

机构信息

Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Medicines Agency, Madrid, Spain.

出版信息

Br J Clin Pharmacol. 2004 Jul;58(1):71-80. doi: 10.1111/j.1365-2125.2004.02133.x.

Abstract

AIMS

To provide quantitative information about the absolute and relative risks of acute and clinically relevant drug-induced liver injury.

METHODS

We performed a population-based case-control study using the UK-based General Practice Research Database as the source of information. A total of 1,636,792 persons subjects aged 5-75 years old registered in the database from 1 January, 1994 to 31 December, 1999 were followed-up for a total of 5,404,705 person-years. Cases were identified by an exhaustive computer search, then reviewed manually and finally validated against the clinical records. Only idiopathic cases serious enough to be referred to hospital or a consultant were selected. A total of 5000 controls were randomly sampled from the person-time of study cohort. Current users were defined if a prescription ended within 15 days of the index date, and nonusers if there was no prescription before the index date.

RESULTS

One hundred and twenty-eight patients were considered as valid cases, being the crude incidence rate of 2.4 (95% confidence interval: 2.0, 2.8) per 100 000 person-years. The strongest associations were found with chlorpromazine (adjusted odds ratio (AOR); 95% CI = 416; 45, 3840), amoxicillin/clavulanic acid (AOR = 94.8; 27.8, 323), flucloxacillin (AOR = 17.7; 4.4, 71.0), macrolides (AOR = 6.9; 2.3, 21.0), tetracyclines (AOR = 6.2; 2.4, 15.8); metoclopramide (AOR = 6.2; 1.8, 21.3); chlorpheniramine (AOR = 9.6; 1.9, 49.7); betahistine (AOR = 15.3; 2.9, 80.7); sulphasalazine (AOR = 25.5; 6.0, 109); azathioprine (AOR = 10.5; 1.4, 76.4), diclofenac (AOR = 4.1; 1.9, 8.8) and antiepileptics (AOR = 5.1; 1.9, 13.7). A dose-effect was apparent for diclofenac, amoxicillin/clavulanic acid and flucloxacillin. The combination of two or more hepatotoxic drugs increased the risk by a factor of 6. The highest crude incidence rates were found for chlorpromazine, azathioprine, and sulfasalazine (about 1 per 1000 users).

CONCLUSIONS

Idiopathic, acute and clinically relevant liver injury, which has the use of drugs as the most probable aetiology, is a rare event in the general population. The relative risks of 40 drugs/therapeutic classes are provided, along with the crude incidence rates for 15 of them where a statistical association was found.

摘要

目的

提供关于急性和临床相关药物性肝损伤的绝对风险和相对风险的定量信息。

方法

我们进行了一项基于人群的病例对照研究,使用英国全科医学研究数据库作为信息来源。对1994年1月1日至1999年12月31日在该数据库中注册的1,636,792名年龄在5至75岁的受试者进行了总计5,404,705人年的随访。通过详尽的计算机搜索识别病例,然后人工复查,最后对照临床记录进行验证。仅选择病情严重到足以转诊至医院或咨询专家的特发性病例。从研究队列的人时中随机抽取5000名对照。如果处方在索引日期后15天内结束,则定义为当前使用者;如果在索引日期前没有处方,则定义为非使用者。

结果

128名患者被视为有效病例,粗发病率为每10万人年2.4例(95%置信区间:2.0,2.8)。发现与氯丙嗪(调整比值比(AOR);95%CI = 416;45,3840)、阿莫西林/克拉维酸(AOR = 94.8;27.8,323)、氟氯西林(AOR = 17.7;4.4,71.0)、大环内酯类(AOR = 6.9;2.3,21.0)、四环素类(AOR = 6.2;2.4,15.8);甲氧氯普胺(AOR = 6.2;1.8,21.3);氯苯那敏(AOR = 9.6;1.9,49.7);倍他司汀(AOR = 15.3;2.9,80.7);柳氮磺胺吡啶(AOR = 25.5;6.0,109);硫唑嘌呤(AOR = 10.5;1.4,76.4)、双氯芬酸(AOR = 4.1;1.9,8.8)和抗癫痫药(AOR = 5.1;1.9,13.7)的关联最强。双氯芬酸、阿莫西林/克拉维酸和氟氯西林存在剂量效应。两种或更多种肝毒性药物联合使用会使风险增加6倍。氯丙嗪、硫唑嘌呤和柳氮磺胺吡啶的粗发病率最高(每1000名使用者中约1例)。

结论

以药物使用为最可能病因的特发性、急性和临床相关肝损伤在普通人群中是罕见事件。提供了40种药物/治疗类别的相对风险,以及其中15种发现有统计学关联的药物的粗发病率。

相似文献

1
Acute and clinically relevant drug-induced liver injury: a population based case-control study.
Br J Clin Pharmacol. 2004 Jul;58(1):71-80. doi: 10.1111/j.1365-2125.2004.02133.x.
2
Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid.
Arch Intern Med. 1996 Jun 24;156(12):1327-32. doi: 10.1001/archinte.1996.00440110099013.
5
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16.
6
Risk of acute liver injury associated with the use of drugs: a multicentre population survey.
Aliment Pharmacol Ther. 2007 Jun 15;25(12):1401-9. doi: 10.1111/j.1365-2036.2007.03338.x.
7
Italian cancer figures, report 2013: Multiple tumours.
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152.

引用本文的文献

1
Choosing a nonsteroidal anti-inflammatory drug for pain.
Aust Prescr. 2025 Aug;48(4):139-144. doi: 10.18773/austprescr.2025.032.
2
Hepatotoxicity associated with statins: A retrospective pharmacovigilance study based on the FAERS database.
PLoS One. 2025 Jul 9;20(7):e0327500. doi: 10.1371/journal.pone.0327500. eCollection 2025.
3
Drug-Induced Liver Injury-Pharmacological Spectrum Among Children.
Int J Mol Sci. 2025 Feb 25;26(5):2006. doi: 10.3390/ijms26052006.
5
Liver diseases: epidemiology, causes, trends and predictions.
Signal Transduct Target Ther. 2025 Feb 5;10(1):33. doi: 10.1038/s41392-024-02072-z.
6
Clinical Practice Guidelines for Topical NSAIDs in the Treatment of Sports Injuries.
J Evid Based Med. 2025 Mar;18(1):e12661. doi: 10.1111/jebm.12661. Epub 2025 Jan 10.
8
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs.
Drug Saf. 2025 Feb;48(2):151-160. doi: 10.1007/s40264-024-01486-6. Epub 2024 Sep 24.

本文引用的文献

3
Association between body mass index and liver disorders: an epidemiological study.
J Hepatol. 2002 Dec;37(6):741-7. doi: 10.1016/s0168-8278(02)00298-2.
5
Incidence of drug-induced hepatic injuries: a French population-based study.
Hepatology. 2002 Aug;36(2):451-5. doi: 10.1053/jhep.2002.34857.
6
Clarithromycin use preceding fulminant hepatic failure.
Am J Gastroenterol. 2002 Feb;97(2):489-90. doi: 10.1111/j.1572-0241.2002.05505.x.
8
Use of the UK General Practice Research Database for pharmacoepidemiology.
Br J Clin Pharmacol. 1998 May;45(5):419-25. doi: 10.1046/j.1365-2125.1998.00701.x.
10
Sulpiride-induced cholestalic jaundice.
Aust N Z J Psychiatry. 1996 Oct;30(5):701-2. doi: 10.3109/00048679609062671.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验